Amundi
ZURA icon

Amundi’s Zura Bio ZURA Stock Holding History

Amundi’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,929
Closed -$40.3K – 2089
2023
Q4 		$40.3K Buy
+9,929
New +$49.6K ﹤0.01% 1909

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Amundi's ZURA Position: Q1 2024 in Review

Amundi sold out of Zura Bio (ZURA) in Q1 2024, closing a stake of 9,929 shares — an estimated $40.3K sold.

Amundi first reported a position in ZURA in Q4 2023 and held it in 1 quarter. The position peaked at $40.3K in Q4 2023. 45 funds tracked by Wall St. Rank hold ZURA as of Q1 2024.

  • Amundi reported no remaining Zura Bio position as of Q1 2024 after selling out during the quarter.
  • Amundi sold 9,929 Zura Bio shares in Q1 2024, an estimated $40.3K.
  • Amundi first reported a position in Zura Bio in Q4 2023 and held it in 1 quarter.
  • Amundi's Zura Bio position peaked at $40.3K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Zura Bio as of Q1 2024.

Based on Amundi's 13F filing for Q1 2024, filed 15 May 2024.